Abstract
Lung and heart-lung transplantation are now established as therapeutic interventions for many terminal conditions affecting the pulmonary system. Unfortunately, the growth in supply of donor lungs has lagged behind demand. Paradoxically, our increasing clinical success exacerbates the donor organ shortage by broadening indications for transplantation and increasing referrals of appropriate patients at an earlier stage in their disease. As a consequence, appropriate organs are often not available in time, and many of those accepted for transplant die waiting. One third of cystic fibrosis patients (181 of 544) listed between 1990 and 1994 died before transplantation; similar mortality occurs for patients with other underlying pathology [1]. The most acute need is among patients with congenital heart disease and those with cystic fibrosis, for both of whom a heart-lung bloc or double lung graft represents their best or only viable option, and patients with idiopathic pulmonary fibrosis, whose unpredictable, often fulminant course frequently results in mortality shortly after listing. Patients with these and other end-stage pulmonary disorders might benefit if xenogeneic lungs were available.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
UNOS Registry statistics
VEITH, F.J., RICHARDS, K.U., HAGSTROM, J.W.C, MONTEFUSCO, CM. Intrafamiliallung xenografts from fox to dog. J. Thorac. Cardiovasc. Surg. 81:546, 1981
TAKEDA, M., KAWAUCHI, M., NAKAJIMA, J., FURUSE, A. Methotrexate in rescue therapy for xenotransplanted lung in primates. (Abstract po-46) Third International Congress for Xenotransplantation, Boston, 1995
SADEGHI, A.M., LAKS, H., DRINKWATER, D.C., et al. Heart-lung xenotransplantation in primates. J. Heart Lung Transplant. 10:442, 1991
MARKMAN, J.F., BARKER, C.F. Basic and clinical considerations in the use of xenografts. Curr. Probl. Surg. 31:385, 1994
CAMPBELL, G.S., CRIPS, N.W., BROWN, E.B. Total cardiac bypass in humans utilizing a pump and heterologous lung oxygenator (dog lungs). Surgery. 40:364, 1956
WALDHAUSEN, J.A., WEBB, R.C. SPENCER, F.C., BAHNSON, H.T. Study of the canine lung as an oxygenator of human and canine blood in extracorporeal circulation. Surgery. 42:726, 1957
BRYANT, L.R., EISEMAN, B., AVERY, M. Studies of the porcine lung as an oxygenator for human blood. J. Thorac. Cardiovasc. Surg. 55:255, 1968
HALMAGYI, D.F.J., STARZECKI, B., MCRAE, J., HORNER, G.J. The lung as the mainc target organ in the acute phase of transfusion reaction in sheep. J. Surg. Res. 3:418, 1963
MORAL, D.R., GYSIN, I., PITTET, J.F., COSTABELLA, P.M.M. Role of thromboxane A2 during incompatible homologous and heterologous blood transfusion in sheep. Anesthesiology. 69:A122, 1988
COOK, W.A., KLAUSNER, S.K., SINHA, S., KIKKAWA, Y, VEITH, F.J. A new look at hyperacute rejection. Ann. Thorac. Surg. 13:388, 1972
TAVAKOLI, R., DEVAUX, J.Y., NONNENMACHER, L., et al. Discordant lung xenograft rejection in the rat. Transplantation. 53:235, 1992
KUSAJIMA, K., WAX, S.D., WEBB, W.R., AUST, J.C. Cinemicroscopy of hyperacute pulmonary rejection. Ann. Thorac. Surg. 21:341, 1976
KUSAJIMA, K., AUST, J.C, WAX, S.D., WEBB, W.R. Hemodynamic and functional changes in xenogeneic, perfused, isolated lungs. J. Thorac. Cardiovasc. Surg. 72:115, 1976
SPEILLER, P.B., KIKKAWA, Y., VEITH, F.J., COOK, WA. Steroid protection of a pulmonary xenograft model. Surg. Forum. 23:272, 1972
PIERSON, R.N. III, TEW, D.N., KONIG, W.K., et al. Pig lungs are susceptible to hyperacute rejection by human blood in a working ex vivo heart-lung model. Transplant. Proc. 26:1318, 1994
PIERSON, R.N. III, DUNNING, J.J., KONIG, W.K., et al. Mechanisms governing the pace and character of pig heart and lung rejection by human blood. Transplant. Proc. 26:2337, 1994
KAPLON, R.J., PLATT, J.L., KWIATKOWSKI, P.A., et al. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation. 59:410, 1995
SHAH, A.S., O’HAIR, D.P., KAPLON, R.J., et al. Absence of hyperacute rejection in pig-to-primate double lung xenografts. (Abstract 188) J. Heart Lung Transplant. 14:S83, 1995
PIERSON, R.N. III, KASPAR-KONIG, W, TEW, D.N., et al. Hyperacute rejection in a pig-to-human lung transplant model. 1: The role of antipig antibody and complement. Transplantation, in the press.
FISCHEL, R.J., DALMASSO, A.P., VERCELLOTTI, G.M., et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140:1157, 1992
PRUITT, S.K., KIRK, A.D., BOLLINGER, R.R., et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation. 57:363, 1994
FUKUSHIMA, N., BOUCHART, E, GUNDRY, S.R., et al. The role of anti-pig antibody in pig-to-baboon cardiac xenotransplant rejection. Transplantation. 57:923, 1994
WHITE, D.J.G., BRAIDLEY, P., DUNNING, J., et al. Hearts from pigs transgenic for human DAF are not hyperacutely rejected when xenografted to primates. (Abstract pl-28) Third International Congress for Xenotransplantation, Boston, 1995
MCCURRY, K.R., KOOYMAN, D., DIAMOND, L., et al. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. (Abstract 288) Fifteenth International Congress of the Transplantation Society, Kyoto, 1994
PIERSON, R.N. III, YOUNG, V.K., KASPAR-KONIG, W, WHITE, D.J.G., WALLWORK, J. Expression of human complement regulatory protein may protect pig lung against hyperacute rejection by human blood. (Abstract 233) J. Heart Lung Transplant. 14:S94, 1995
NORIN, A.J., BREWER, R.J., FODOR, W.L., et al. Enhanced survival of porcine endothelialized PTFE vascular grafts and porcine lung xenografts in primates expressing human CD59. (Abstract po-39) Third International Congress for Xenotransplantation, Boston, 1995
DAVIS, D. Personal communication
PIERSON, R.N. III, TEW, D.F., KONIG, W.K., WHITE, D.J.G., WALLWORK, J. Profound pulmonary hypertension, characteristic of pig lung rejection by human blood, is mediated by xenoreactive antibody independent of complement. Transplant. Proc. 27:274, 1995
MULLIGAN, M.S., PAULSON, J.C., DE FREES, S., et al. Protective effects of oligosac- charides in P-selectin-dependent lung injury. Nature. 364:149, 1993
COLLETTI, L.M., BURTCH, G.D., REMICK, D.G., et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation. 49:268, 1990
WHEELER, A.P., JESMOK, G., BRIGHAM, K.L. Tumor necrosis factor’s effects on lung mechanics, gas exchange, and airway reactivity in sheep. Am. J. Physiol. 161:2542, 1990
BANDO, K., PILLAI, R., CAMERON, D.E., et al. Leukocyte depletion ameliorates free radicalmediated lung injury after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 99:873, 1990
DUKE, S.S., GUERRY-FORCE, M.L., FORBES, J.T., et al. Acute endotoxin-induced lym-phocyte subset sequestration in sheep lungs. Lab. Invest. 62:355, 1990
YOUNG, V.K., PIERSON, R.N. III, KASPAR-KONIG, W, et al. White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood. Transplant. Proc. 27:272, 1995
PIERSON, R.N. III, PARKER, R.E. Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood. Transplant. Proc. 28:635, 1996
ROSENGARD, A.M., CARY, N.R., LANGFORD, G.A., TUCKER, A.W., WALLWORK, J., WHITE, D.J.G. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 59(9):1325–33, 1995
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pierson, R.N., Pino-Chavez, G. (1997). Experimental Lung Xenografting. In: Cooper, D.K.C., Kemp, E., Platt, J.L., White, D.J.G. (eds) Xenotransplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60572-7_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-60572-7_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64460-3
Online ISBN: 978-3-642-60572-7
eBook Packages: Springer Book Archive